Cargando…
An Overview of the Genomic Characterization of Hepatocellular Carcinoma
Tumor classifications based on alterations in the genome, epigenome, or proteome have revealed distinct tumor subgroups that are associated with clinical outcomes. Several landmark studies have demonstrated that such classifications can significantly improve patient outcomes by enabling tailoring of...
Autores principales: | Yim, Sun Young, Lee, Ju-Seog |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8434863/ https://www.ncbi.nlm.nih.gov/pubmed/34522690 http://dx.doi.org/10.2147/JHC.S270533 |
Ejemplares similares
-
Genomic Perspective on Mouse Liver Cancer Models
por: Yim, Sun Young, et al.
Publicado: (2019) -
The mutational landscape of hepatocellular carcinoma
por: Lee, Ju-Seog
Publicado: (2015) -
Glutamine synthetase mediates sorafenib sensitivity in β-catenin-active hepatocellular carcinoma cells
por: Sohn, Bo Hwa, et al.
Publicado: (2018) -
Clinical Significance of Glycolytic Metabolic Activity in Hepatocellular Carcinoma
por: Jung, Joann, et al.
Publicado: (2022) -
An overview of mouse models of hepatocellular carcinoma
por: Zheng, Hua-chuan, et al.
Publicado: (2023)